On April 22, 2026, Indaptus Therapeutics, Inc. appointed Tim Ruan and Dr. Yi Zhang as independent directors, while Matthew McMurdo resigned. Mr. Ruan will receive a $30,000 annual retainer and serve on the Audit Committee, while Dr. Zhang will join the Nominating Committee.